Avid Bioservices Inc (CDMO)

[exwannabe]

jq1234, here is some more info that may change your mind regarding the use of blood samples which will be allowing the FDA to make approvals and Roche just had a drug approved based on this very method - of blood samples.

I would not think a pCR in any way equates to using some sort of immune assay as a suragate endpoint.

I would have no issue if people here were suggesting some sort of PR/CR endpoint for approval. That shows that the cancer is being killed. Kind of reasonable to assume that this will be a clinical benefit..

But an immune response (as of now) does not do such. All this shows is that the immune system is reacting to the drug.